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Abstract
Impaired endothelium-dependent vasodilation has been associated with decreased NO bioavailability in hypercholesterolemia.
This study aimed to determine whether antioxidant vitamins C and E could improve hypercholesterolemia-derived endothelial
dysfunction in the porcine model, and whether observed in vivo results could be reproduced in vitro by incubation of coronary
endothelial cells (EC) in the presence of native low-density lipoproteins (LDL). Adult mini-pigs were fed standard (C), cholesterol
rich (HC) or cholesterol rich diet supplemented with vitamins C and E (HCV). Endothelium-dependent blood flow increase in
response to acetylcholine was determined. Endothelial nitric oxide synthase (eNOS) expression was measured in arterial samples and
in EC incubated with LDL isolated from porcine plasma. Vasomotor response to acetylcholine in HC was significantly lower (PB/
0.05) than control and HCV. There was a significant (PB/0.05) decrease in eNOS immunoreactivity in HC, compared with HCV
and control. Native LDL from HC, but not from HCV, induced a significant decrease in eNOS expression. Vitamins C and E
treatment improved the endothelium-dependent vasomotor capacity and prevented decreased expression of eNOS in hypercho-
lesterolemic pigs. A similar effect could be demonstrated in vitro, by incubation of EC with native LDL, suggesting that the effect of
physiologically-modified LDL on eNOS could have a role in recovering vascular function.# 2002 Elsevier Science Ireland Ltd. All
rights reserved.
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1. Introduction
The vascular endothelium plays an important role in
the regulation of the arterial vasomotor tone, mainly by
the synthesis and release of vasoactive substances such
as endothelium-derived relaxing factor, identified as
nitric oxide (NO) or a closely related compound [1],
endothelium-derived hyperpolarizing factor and prosta-
cyclin. NO reduces vessel tone, interferes with monocyte
and leukocyte adhesion to vascular endothelium, de-
creases platelet aggregation and adhesion, and inhibits
smooth muscle proliferation and migration. In vivo, the
activity of the L-arginine-NO pathway results from a
balance between the synthesis and breakdown of NO [2].
Hyperlipidemia and atherosclerosis are associated
with abnormalities of the vascular function character-
ized both by an increase in the response to specific
vasoconstrictor agents and marked attenuation of
endothelium-dependent relaxation, although the exact
mechanisms still remain unknown [3]. There is a large
body of evidence supporting the notion that oxidation
of lipids and lipoproteins may contribute to the patho-
* Corresponding author. Tel.: /34-948-425600; fax: /34-948-
425649
E-mail address: josean@unav.es (J.A. Rodrı´guez).
Atherosclerosis 165 (2002) 33/40
www.elsevier.com/locate/atherosclerosis
0021-9150/02/$ - see front matter # 2002 Elsevier Science Ireland Ltd. All rights reserved.
PII: S 0 0 2 1 - 9 1 5 0 ( 0 2 ) 0 0 1 8 8 - 0
genesis of atherosclerosis, suggesting a number of
potential mechanisms by which intra-arterial oxidation
of lipoproteins might initiate and promote atherogenesis
[4,5]. It has been shown in vitro that impairment of NO
production in hypercholesterolemia can be due to
reduced transcription and enhanced breakdown of
endothelial constitutive NO synthase (eNOS) transcripts
[6], or modulation of caveolin abundance in endothelial
cells (EC) [7]. Alternatively, diminished NO activity
could be due to a decrease in NO production, by
reduced availability of L-arginine or tetrahydrobiop-
terin, or caused by enhanced catabolism: increased
endothelial superoxide production may inactivate en-
dothelium-derived NO and provide a source for other
oxygen radicals, contributing to the early atherosclerotic
process [8].
A number of studies in different animal models have
considered the potential for different dietary antioxi-
dants to help prevent development and progression of
atherosclerosis. Vitamin C, vitamin E, b-carotene,
probucol and selenium, alone or combined, have been
evaluated in several studies and most of the experi-
mental evidence helps substantiate this hypothesis [5,9],
but is not yet conclusive [10]. Vascular dysfunction
associated with hypercholesterolemia has been shown to
be prevented in experimental animals and human
individuals by dietary supplementation with vitamin C
and/or E [11,12].
In the present study we investigated whether antiox-
idant vitamins C and E could improve hypercholester-
olemia-derived endothelial dysfunction in the porcine
model, and whether observed in vivo results could be
reproduced in vitro by incubation of coronary EC in the
presence of native low-density lipoproteins (LDL).
Treatment with vitamins was initiated 3 weeks after
the induction of hypercholesterolemia, to more closely
mimic a potential clinical situation.
2. Material and methods
2.1. Experimental design
Thirty-six male Yucatan miniature pigs (4 months
old; mean weight, 33.39/1.69 kg), procured from our
breeding center, were maintained in a humidity- and
temperature-controlled room. The investigation was
performed in accordance with the European Commu-
nity guidelines for animal ethical care and use of
laboratory animals (Directive 86/609), and was ap-
proved by the Animal Research Ethics Committee of
University of Navarra.
Animals were divided into three groups and fed
during 5, 6 or 8 weeks, to assess the potential impact
of time on the effect of vitamin supplementation, using
the following dietary formulations: standard porcine
chow (Porcisanders, Sanders, Spain) (C, n/12); high-
cholesterol diet (HC, n/12) containing 24.5% animal
lard, 4% cholesterol (Roig Farma, Spain) and 1.5%
biliar extract (Roig Farma); and a HC plus vitamins C
and E (HCV, n/12) fed in the same way as HC for 3
weeks, and supplemented thereafter (up to 5, 6 or 8
weeks) with 1 g ascorbic acid and 1000 IU D,L-a-
tocopherol acetate (Roig Farma) per animal and day.
2.2. Animal experiments
Each animal was fasted overnight before the day of
the study, but allowed ad libitum access to tap water.
Animals were sedated, intubated and ventilated through
an endotracheal tube. Anesthesic induction was com-
pleted by i.v. injection of metomidate 2 mg/kg (Esteve
Veterinaria, Spain), 0.2 mg/kg pancuronium bromide
(Organon, The Netherlands) and 0.05 mg fentanyl
(Roche, Switzerland) were given to maintain a constant
level of anesthesia. The right internal jugular vein and
carotid artery were exposed by cutdown and cannulated.
Arterial blood samples for blood cell count and lipid
profiles were collected in tubes containing EDTA. After
i.v. injection of a bolus of 10 000 U heparin, a 7F
Judkins coronary guiding catheter was used to engage
the left internal iliac artery (LIIA). A flexible angio-
plasty guidewire of 0.35 mm (0.014 in.) was advanced
into the lumen of a 3F Doppler catheter (NuVel,
NuMed Inc, USA) connected to a 20 MHz pulsed
Doppler velocimeter (MDV-20, Millar Instruments,
USA), and positioned into the non-branching medial
section of the LIIA; the guiding catheter was then
retracted to abdominal aorta. Doppler flow velocity
(maximum velocity and average peak velocity) was
recorded continuously in a chart recorder (Hewlett-
Packard, USA).
Animals were allowed a 15 min equilibration period
to ensure stability, and 4.8 ml of 0.28 mol/l glucose was
selectively infused for 2 min into the LIIA via the
infusion lumen of the Doppler catheter. In a similar
fashion, 2.4 ml of acetylcholine (Sigma, USA) at
concentrations of 106, 105 and 104 mol/l (to
achieve estimated final blood concentrations of 108,
107 and 106 mol/l, assuming iliac blood flow of
aproximately 80 ml/min) was selectively infused into the
LIIA, lasting 1 min for each concentration. The
endothelium-independent vasodilator capacity was as-
sessed by injecting 1 mg nitroglycerin (NTG) into the
LIIA. A 5 min recovery period was allowed between
each injection, until blood flow returned to basal values.
At the end of the procedure, iliac angiographic images
were recorded and animals were sacrificed by an i.v.
dose of 65 mg/kg pentobarbital (Sigma) followed by a
bolus of KCl.
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2.3. Blood analysis
Platelet, red and white blood cell count, platelet size,
were determined in blood anticoagulated with EDTA,
using a Coulter SKTS counter (Coulter Electronics,
USA).
Serum total cholesterol (TC), triglycerides (TG) and
high density lipoprotein (HDL) cholesterol were mea-
sured by an enzymatic method, using a fully automated
clinical analyzer (Hitachi 717, Roche). Low-density
lipoprotein (LDL) cholesterol was calculated with
Friedewald formula [13], modified for the ratio choles-
terol/TG in very low-density porcine lipoproteins (8:1).
2.4. Vitamin E content
a-Tocopherol (AT) was measured in plasma and LDL
by normal-phase high-performance liquid chromatogra-
phy [14]. After addition of AT acetate as internal
standard to each sample, vitamin E was extracted
from 200 ml of plasma or 50 ml of LDL (4 mg
cholesterol/ml) with hexane (800 ml), following the
addition of methanol (200 ml). The samples were
centrifuged at 1500/g for 15 min, evaporated under
nitrogen and separated on a mBondapack C18 column
(3.9/300 mm2, Waters, USA). The mobile phase
consisted of acetonitrile/methanol/H2O (49:48:3)
pumped at a flow rate of 1 ml/min. AT was quantifed
spectrophotometrically at 292 nm.
2.5. Low-density lipoprotein isolation
LDLs in density range of 1.019/1.063 g/ml were
isolated from porcine plasma by density gradient ultra-
centrifugation [15]. Addition of EDTA (1 mmol/l, pH
7.4) and butylated-hydroxytoluene (BHT, 1 mmol/l)
prevented oxidation of LDL throughout the isolation.
The LDL fraction was extensively dialyzed against 0.15
M NaCl, 1 mmol/l EDTA (pH 7.4) and 1 mmol/l BHT,
sterile filtered (0.2-mm pore size Syringe-Prefilter Plus,
Nalgene, USA), and stored at 4 8C. LDL protein was
determined by Lowry’s method [16], and cholesterol was
measured enzymatically as described [17]. LDL char-
acterization was completed by electrophoretic mobility
on 3% SDS-polyacrylamide gels and measurement of
AT content. LDLs were dialyzed overnight against cell
culture medium (10 000 MWCO Slyde-A-Lyzer, Pierce,
USA) before addition to cell cultures.
2.6. Cell culture
Coronary arteries from untreated pigs were used to
obtain normal EC cultures by enzymatic dispersion [18].
Arteries were cut longitudinally and intima was digested
with 0.2 mg/ml chymotrypsin (Sigma) in PBS for 10 min.
EC were gently scraped off with a cotton swab and
transferred to gelatin-coated culture dishes containing
M199 culture medium and 20% pig serum (Linus,
Spain), supplemented with antibiotic/antimycotic solu-
tion. Experiments were carried out on subcultured
passage 3/4 cells, after reaching confluency and 48 h
of adaptation to serum-free endothelial medium. The
purity of cultures was determined on the basis of their
characteristic cobblestone morphology and absence of
smooth muscle-a-actin staining. AT was from Merck,
ascorbic acid was from Sigma, all the other cell culture
reagents were from GIBCO-BRL (Invitrogen SA,
Spain).
2.7. Protein extraction, electrophoresis and western
blotting
After stimulation, EC were washed and disrupted
with homogenization buffer containing 1.8 mM
NaH2PO4, 1.6 mM Na2HPO4, 50 mM NaCl, 0.1%
SDS, 0.5% sodium azide, 1% Triton X-100, and a
protease-inhibitor cocktail (Complete EDTA-free,
Roche). Protein concentration was determined accord-
ing to Bradford [19].
Cell lysates (15 mg total protein) were subjected to
12% SDS-polyacrylamide gel electrophoresis. Proteins
were electroblotted onto nitrocellulose membranes and
probed with anti-eNOS (1:2000, N30020, Transduction
Laboratories, USA), followed by a peroxidase-linked
sheep anti-mouse IgG (1:5000, Amersham-Pharmacia
Biotech Europe, Germany). Blots were developed by
enhanced chemiluminescence according to the manufac-
turer’s instructions. Even loading was verified by
Ponceau red staining.
2.8. Tissue processing and eNOS immunostaining
The iliac arterial tree was dissected, perfused with 4%
paraformaldehyde at 4 8C for 15 min, and left in 4%
paraformaldehyde at 4 8C for 4 h. Arteries were cut to 1
cm long pieces and paraffin embedded (up to 8 pieces
per block).
A standard avidin/biotin peroxidase complex method
was used for immunostaining [5]. Three-micrometer
sections were deparaffinized and rehydrated, endogen-
ous peroxidase was inhibited with 3% H2O2/Tris-buf-
fered saline and nonspecific binding was blocked by
incubation with 5% normal rabbit serum. Specimens
were incubated with a monoclonal antibody recognizing
eNOS (1:300, N30020, Transduction Laboratories) at
4 8C overnight. Sections were incubated with biotiny-
lated secondary rabbit anti-mouse antibodies (1:200,
Dako, Denmark), and developed with avidin/biotin
complexes (1:100, ABC, Dako), according to the
manufacturer’s instructions.
Immunohistochemical processing was done in batches
of 12 slides, including internal control sections (scored
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‘0’ and ‘3’). At least 2 histological slides from each
animal, containing up to 5 sections of the LIIA, were
processed as described before and reviewed by five
independent observers in a blinded fashion. Arterial
sections with atherosclerotic lesions or intimal thicken-
ing were excluded from the study. A visual grading score
system to quantify endothelial staining for eNOS was
established as follows: 0, no staining; 1, positive staining
in B/25% endothelium; 2, positive staining in /25%
but B/75%; 3, positive staining in /75%. The score for
each slide was calculated as the median score between
observers.
2.9. Data analysis
All data are presented as mean value9/S.E.M. Ana-
lysis of variance (ANOVA) or Kruskal/Wallis test were
applied to assess differences between treatment groups.
After a significant ANOVA or Kruskal/Wallis, com-
parisons were made with Bonferroni posthoc or Mann/
Whitney test, respectively. Statistical significance was
accepted at the 95% confidence level (PB/0.05). Analy-
sis was performed by using the computer program
SIGMASTAT (SPSS Science, USA).
3. Results
3.1. Animal model characteristics
The comparison among animals from the same group
sacrificed at different times (5, 6 or 8 weeks) showed no
statistical differences in any of the studied parameters,
and therefore they are presented together. Animals from
all groups had similar body weight at the beginning of
the experiment. After treatment, as shown in Table 1,
weight gain in HC (89%) and HCV (84%) was higher
(PB/0.05) than in the control (44%).
There were no differences in baseline values of
hematocrit, white blood cell count and platelet count
between groups. These values did not change signifi-
cantly after diet and were similar in all groups.
3.2. Plasma lipids and vitamin E
Baseline concentrations of TC, HDL and LDL were
similar in all groups. The hypercholesterolemic diet
substantially increased (up to 250%) TC levels in HC
and HCV at the time of sacrifice (Table 1). The increase
in TC levels could be attributed primarily to elevated
LDL levels, although HDL levels were also higher.
Treatment with vitamins C and E had no effect on TC
and LDL concentration at the time of sacrifice, but
HDL concentration in this group was 20% higher than
in the HC. None of the experimental diets influenced
TG concentration. AT plasma levels in HCV were
significantly higher than C and HC (PB/0.05), but no
differences were observed between the three time
periods.
3.3. LDL characterization
Vitamin E content of LDL, expressed as AT/protein
ratio, was similar in C and HC groups while it was
significantly higher in HCV, as expected from the
observed plasmatic levels of AT. Nevertheless, hyperch-
olesterolemic animals exhibited a significantly decreased
AT/cholesterol ratio in LDL, as compared with C and
HCV groups (Table 2).
HC/LDL lipid load was significantly higher (PB/
0.05) than C/LDL, being HCV/LDL even higher
(PB/0.05; Table 2). These changes in lipid composition
affected LDL size, as reflected by the different electro-
phoretic mobilities: HC/ and HCV/LDL migrated
more slowly than C/LDL on 3% SDS-polyacrylamide
gels (data not shown).
Table 1
Animal weight, plasma TC (mmol/l), HDL (mmol/l), LDL (mmol/l), TG (mmol/l) and a-tocopherol (mmol/l), at baseline (A) and at the end of the
experiment (B)
Group Weight (kg) Total cholesterol LDL HDL TG a-tocopherol
A. Before treatment
C 3293 1.6490.11 0.6090.08 0.9090.05 0.4790.04
HC 3193 1.5690.05 0.5490.06 0.8590.05 0.4990.04
HCV 3193 1.5390.06 0.5190.03 0.9190.05 0.5390.03
B. Sacrifice
C 4691 1.6190.08 0.6590.06 0.8090.04 0.4790.05 2.0090.41
HC 5592 5.0290.62** 3.4990.53** 1.2390.07** 0.4390.07 1.6790.22
HCV 5393 5.2990.65** 3.2690.45** 1.5790.12**$ 0.3590.05 14.0493.66*
Values are expressed as mean9S.E.M. Statistically significant differences from control group are marked as *(PB0.05) or **(PB0.01), and
between HC and HCV as $(PB0.05).
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3.4. Hemodynamics
At the time of sacrifice, increases in blood flow
velocity in the LIIA of control animals ranged from 75
to 200%, in response to increasing concentrations (106,
105 and 104 mol/l) of acetylcholine (Table 3).
Infusion with the same volume of saline did not affect
blood flow velocity, showing that flow changes were
specifically induced by acetylcholine. HC pigs, but not
HCV animals, exhibited a significant reduction in the
blood flow velocity increase (40/50%) in response to
acetylcholine when compared with controls (PB/0.05).
The endothelium-independent arterial relaxation, in
response to NTG perfusion, was similar (about 120%)
in all groups.
No significant correlation was found between dura-
tion of treatment and increase of blood flow velocity.
Since no differences between animals within the same
group and sacrificed at different times were observed,
data are presented together.
3.5. eNOS expression in vivo
Hematoxylin-eosin staining of arterial sections re-
vealed intact endothelial structure in all groups, with
occasional areas of intimal thickening more frequently
in the HC animals. Staining for eNOS revealed an
overall decrease in the presence of enzyme immunor-
eactivity after 5/8 weeks of cholesterol-rich diet, in
comparison with normal animals (Fig. 1; C, HC). This
reduction could be reversed by supplementing the
hypercholesterolemic diet with vitamins C and E (Fig.
1; HCV). There were no noticeable differences between
animals within the same group and sacrificed at
different time points (5, 6 and 8 weeks of diet). Results
from the scoring system for constitutive eNOS showing
statistically significant differences between HC and
control (PB/0.05), and HC and HCV (PB/0.05) can
be observed in Fig. 1(upper panel). No significant
correlation was found between treatment length and
eNOS score.
3.6. eNOS expression in vitro
Incubation of normal porcine coronary EC with 100
mg (protein)/ml LDL induced a time-dependent reduc-
tion in eNOS expression in all cases. LDL from HC
animals markedly inhibited eNOS expression at 48 and
96 h (60 and 80% reduction in respect to basal value), as
compared both with baseline and EC incubated with
LDL from control group. However, native LDL from
HCV did not exert that inhibitory effect on EC (Fig. 2).
Additional experiments were performed (in triplicate),
and the addition of ascorbic acid (14 mM) and AT (14
mM) to the culture medium completely prevented the
inhibitory effect of HC-LDL on eNOS expression (929/
6% with respect to non-treated cells at 48 h).
4. Discussion
The present study is the first to show that native LDL
isolated from hypercholesterolemic animals downregu-
late eNOS expression in coronary EC in vitro, whereas
Table 2
LDL characteristics: AT content of LDL, expressed in relation to LDL cholesterol or protein, and cholesterol/protein ratio
Group nmol a-Tocopherol/mmol cholesterol nmol a-Tocopherol/mg protein mmol Cholesterol/mg protein
C 1.1490.18 4.7690.74 4.1990.20
HC 0.5390.11* 4.5290.72 9.5290.65*
HCV 1.1990.10 13.7791.58** 13.1190.67*$
HC/LDL show a significant reduction in AT/cholesterol content, while in HCV/LDL this ratio is restored to control levels. C/LDL and HC/
LDL carry similar amounts of AT, while HCV/LDL transport a significantly higher amount of AT. Statistically significant differences from control
group are marked as *(PB0.05) or **(PB0.01), and between HC and HCV as $(PB0.05).
Table 3
Changes in iliac artery blood flow velocity (reported in cm/s), in response to increasing doses of acetylcholine and nitroglycerin (1 mg) in the three
groups of animals
Acetylcholine
Group B Saline 106 mol/l 105 mol/l 104 mol/l Nitroglycerin
C 5.0590.93 5.1690.98 8.6192.29 11.4992.32 14.2293.34 11.5392.14
HC 5.3091.47 5.4791.61 7.0792.5* 9.0293.4* 11.1693.94* 10.1493.82
HCV 5.2591.15 5.2891.31 8.1492.8 11.7893.28 15.7894.94 10.9993.98
Vascular response to acetyl choline was significantly reduced (*PB0.05) in hypercholesterolemic pigs (HC), as compared with controls (C) and
vitamin CE treated hypercholesterolemic (HCV) group.
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dietary treatment with vitamins C and E prevents this
inhibitory effect through LDL modification. These
results confirm our in vivo observations: reduced
eNOS expression in porcine arteries and impaired
endothelium-dependent vasodilatory function induced
by hypercholesterolemia, can be prevented by dietary
supplementation with vitamins C and E.
Characteristics of the animal model were similar to
previous studies [20]: animals fed a hypercholesterolemic
diet showed higher weight gain and plasma cholesterol
levels. Dosage of antioxidants was chosen from a similar
model demonstrating that animals treated with vitamins
C and E have smaller degree of LDL oxidation and best
response to vascular injury [21]. Treatment with vita-
mins C and E increased significantly plasma and LDL
concentration of AT. However, it did not modify TG,
total and LDL cholesterol levels, but increased signifi-
cantly the HDL level. We did not find significant
differences in hematologic parameters.
Endothelial dysfunction in pigs fed a cholesterol-rich
diet was demonstrated by the marked increase of
hindlimb vascular resistance, and a fainter and less
extended expression of eNOS as previously reported [3].
Observed endothelial dysfunction cannot be attributed
exclusively to reduced NO bioavailability, since most of
agonist-induced endothelium-dependent dilatation in
peripheral circulation seems to be mediated by EDHF
[22].
Incubation of coronary EC with HC/LDL induced a
marked downregulation of eNOS expression, starting at
48 h and more evident at 96 h, similarly to previous
Fig. 1. Upper panel: semi-quantitative analysis of eNOS immunos-
taining in LIIA. Score frequency is represented on the Y -axis and the
different scores for the three experimental groups are on the X -axis
(explanations are given in the text). C, control; HC, hypercholester-
olemic; HCV hypercholesterolemic treated with vitamins C and E.
(*PB/0.05; Kruskal/Wallis, Mann/Whitney). Lower panel: repre-
sentative photomicrographs of LIIA from control animals (C) showing
strong endothelial immunostaining signal for eNOS, which is practi-
cally absent in HC, whereas HCV animals exhibited a significant
recovery in eNOS expression. Scale bar: 10 mm.
Fig. 2. Coronary porcine EC eNOS expression after incubation with
100 mg (protein)/ml native LDL from C, HC or HCV pigs, at 48 and 96
h. Upper panel: representative western blot, including samples
corresponding to cells before (T0) and after switching to serum-free
media (B). Lower panel: densitometric analysis of five different
experiments, eNOS expression referred to basal (B). Incubation of
coronary EC with native LDL from hypercholesterolemic animals
significantly reduced eNOS expression at 48 and 96 h (*PB/0.05), but
native LDL from C and HCV did not exert this inhibitory effect. EC
were maintained under serum free conditions.
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findings for native and oxidized LDL [23,24]. Interest-
ingly, there is an apparent contradiction with recent
reports showing an increase in caveolin, without changes
in eNOS expression in bovine aortic EC in the presence
of human LDL from subjects with hypercholesterolemia
[7]. The different origin (vascular bed and animal) of the
cells and the heterologous nature of the stimulus
(human LDL vs bovine cells) could account for some
of the differences. In vitro effects of LDL could be
attenuated by the presence of AT in the culture medium
(18 nmol/l), so that differences in eNOS expression
could be enhanced in its absence. Our observations
suggest that regulation of eNOS expression could be one
of the key players in the vascular dysfunction in this
model of porcine hypercholesterolemia, although it does
not discard other factors acting and performing an
important role in the onset and maintenance of the
dysfunction.
The observed negative effect of HC/LDL on eNOS
expression could be due to their higher susceptibility to
oxidation, as reflected by their reduced AT/cholesterol
ratio. Although EC can oxidize LDL in vitro, differ-
ences in lipid composition between C/ and HC/LDL
and in LDL agreggability, and the possible higher lipid
uptake by EC in the presence of HC/LDL, carrying
three times more fat than C/LDL, should be taken into
consideration.
Dietary supplementation of hypercholesterolemic an-
imals with vitamins C and E increased significantly AT
level in plasma and LDL AT/protein ratio, as expected
from the smaller extent of LDL oxidation observed in a
similar model [21], and it also brought LDL AT/
cholesterol ratio back to normal levels. Vitamin treat-
ment was accompanied by the restoration of vasodilator
activity, as had been reported in a rabbit model [25].
This functional improvement was accompanied by an
increase in eNOS expression, as immunohistochemically
shown in the LIIA of HCV pigs, reaching similar
extension and intensity to those observed in controls.
HCV/LDL, in spite of their relative similarity to
HC/LDL in size and lipid load, exhibited different
effects in vitro, reproducing our in vivo observations.
Coronary EC incubated in presence of HCV/LDL for
48 h showed similar eNOS expression to the C/LDL-
treated ones, and slightly higher at 96 h. This observa-
tion, together with the increased AT/cholesterol and AT/
protein ratio for the HCV/LDL, seems to indicate that
HCV/LDL can stand unmodified in the cellular envir-
onment for a longer time, because of a lesser suscept-
ibility to endothelial oxidative modification, thus
avoiding eNOS downregulation due to a direct effect
of oxidized LDL. The fact that the simultaneous
addition of ascorbic acid and AT prevented completely
the inhibitory effect of HC/LDL on eNOS expression
further supports this hypothesis. Vitamin E in LDL
particles acts as a chain-breaking antioxidant, prevent-
ing lipid peroxidation of polyunsaturated fatty acids and
modification of proteins by reactive oxygen species [26].
However, LDL is a major vehicle for vitamin E delivery
to peripheral tissues [27] and AT availability for EC
could differ according to in vivo experimental condi-
tions, indicating that a direct action of AT on EC
metabolism cannot be ruled out [28].
The absence of differences between animals sacrificed
at different time periods should be interpreted cau-
tiously: it seems to indicate effects of hypercholester-
olemia are maximal at 5 weeks and benefits of vitamin
supplementation are maximal after 1 week of treatment.
In this sense, recent reports in a porcine model have
shown vascular reactivity in animals fed a hypercholes-
terolemic diet for 2 and 4 weeks was similar to normal
animals, but it was significantly attenuated in pigs
receiving the same diet for 6 and 12 weeks [29]. More-
over, it has been described in a similar model that serum
vitamin E levels remained unchanged after 1 or 3 weeks
of dietary supplements [21]. However, in our experi-
mental design time periods could be too short to find
significant differences, and small size of experimental
groups (n/4) compromises statistical sensitivity.
Further experimentation should be carried out, in larger
sized groups, to precisely define the effect of time on
studied parameters.
In our animal model, vitamin C and E supplementa-
tion have a clear beneficial effect in hypercholesterole-
mia-derived vascular dysfunction, in agreement with
most of the experimental research work and some
clinical trials (Nurses’ Health Study, CHAOS) [30].
Their effects have been explained mainly through their
antioxidant properties, superoxide anion scavenging
activity or direct effect on the vascular wall. In contrast,
more recent studies (GISSI and HOPE trials) reported
that vitamin E treatment had no positive effects on
cardiovascular disease patients [30]. Aside from the
intrinsic differences between the human and the various
animal models, the higher homogeneity between experi-
mental conditions, together with the exhaustive control
of housing conditions and dietary intake, can reason-
ably explain why results obtained in experimental
studies are more consistent, emphasizing that the
vitamin E status should be properly assessed before
antioxidant treatment in patients with hypercholester-
olemia. Defining the most susceptible patient popula-
tions will be necessary for the development of specific
and efficacious approaches to antioxidant therapy.
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